Medical - Devices
Compare Stocks
4 / 10Stock Comparison
OWLT vs INVA vs PRGO vs SNBR
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
Drug Manufacturers - Specialty & Generic
Furnishings, Fixtures & Appliances
OWLT vs INVA vs PRGO vs SNBR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Devices | Biotechnology | Drug Manufacturers - Specialty & Generic | Furnishings, Fixtures & Appliances |
| Market Cap | $17.66B | $1.93B | $1.61B | $69M |
| Revenue (TTM) | $107M | $424M | $4.18B | $1M |
| Net Income (TTM) | $-46M | $504M | $-1.82B | $-132K |
| Gross Margin | 50.8% | 76.2% | 34.2% | 59.0% |
| Operating Margin | -10.5% | 14.8% | -4.1% | -3.3% |
| Forward P/E | — | 11.9x | 5.6x | — |
| Total Debt | $13M | $269M | $3.97B | $354M |
| Cash & Equiv. | $36M | $551M | $532M | $2M |
OWLT vs INVA vs PRGO vs SNBR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| Owlet, Inc. (OWLT) | 100 | 3.6 | -96.4% |
| Innoviva, Inc. (INVA) | 100 | 218.1 | +118.1% |
| Perrigo Company plc (PRGO) | 100 | 24.3 | -75.7% |
| Sleep Number Corpor… (SNBR) | 100 | 4.4 | -95.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: OWLT vs INVA vs PRGO vs SNBR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
OWLT is the clearest fit if your priority is growth exposure.
- Rev growth 35.4%, EPS growth -169.9%, 3Y rev CAGR 15.2%
- 35.4% revenue growth vs SNBR's -99.9%
INVA carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 94.9% 10Y total return vs PRGO's -77.7%
- Lower volatility, beta 0.13, Low D/E 22.9%, current ratio 14.64x
- Beta 0.13, current ratio 14.64x
- 118.9% margin vs PRGO's -43.5%
PRGO is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 10 yrs, beta 1.18, yield 9.8%
- Better valuation composite
- 9.8% yield; 10-year raise streak; the other 3 pay no meaningful dividend
SNBR lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.4% revenue growth vs SNBR's -99.9% | |
| Value | Better valuation composite | |
| Quality / Margins | 118.9% margin vs PRGO's -43.5% | |
| Stability / Safety | Beta 0.13 vs SNBR's 2.70 | |
| Dividends | 9.8% yield; 10-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +21.7% vs SNBR's -56.8% | |
| Efficiency (ROA) | 32.4% ROA vs OWLT's -58.6%, ROIC 14.2% vs -48.1% |
OWLT vs INVA vs PRGO vs SNBR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
OWLT vs INVA vs PRGO vs SNBR — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
INVA leads in 4 of 6 categories
PRGO leads 2 • OWLT leads 0 • SNBR leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
INVA leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PRGO is the larger business by revenue, generating $4.2B annually — 2960.3x SNBR's $1M. INVA is the more profitable business, keeping 118.9% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, INVA holds the edge at +10.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $107M | $424M | $4.2B | $1M |
| EBITDAEarnings before interest/tax | -$11M | $86M | $58M | $72M |
| Net IncomeAfter-tax profit | -$46M | $504M | -$1.8B | -$132,000 |
| Free Cash FlowCash after capex | -$10M | $181M | $108M | -$21M |
| Gross MarginGross profit ÷ Revenue | +50.8% | +76.2% | +34.2% | +59.0% |
| Operating MarginEBIT ÷ Revenue | -10.5% | +14.8% | -4.1% | -3.3% |
| Net MarginNet income ÷ Revenue | -42.5% | +118.9% | -43.5% | -9.4% |
| FCF MarginFCF ÷ Revenue | -9.7% | +42.8% | +2.6% | -14.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.6% | +10.6% | -7.2% | -3.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.3% | +4.0% | -56.4% | -11.2% |
Valuation Metrics
PRGO leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than INVA's 8.1x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $17.7B | $1.9B | $1.6B | $69M |
| Enterprise ValueMkt cap + debt − cash | $17.6B | $1.7B | $5.1B | $422M |
| Trailing P/EPrice ÷ TTM EPS | -2.17x | 6.91x | -1.14x | -0.53x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.91x | 5.56x | — |
| PEG RatioP/E ÷ EPS growth rate | — | 0.67x | — | — |
| EV / EBITDAEnterprise value multiple | — | 8.10x | 7.42x | — |
| Price / SalesMarket cap ÷ Revenue | 167.06x | 4.55x | 0.38x | 49.07x |
| Price / BookPrice ÷ Book value/share | 77.22x | 1.65x | 0.55x | — |
| Price / FCFMarket cap ÷ FCF | — | 9.88x | 11.12x | — |
Profitability & Efficiency
INVA leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
INVA delivers a 46.5% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $-6 for OWLT. INVA carries lower financial leverage with a 0.23x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), INVA scores 5/9 vs SNBR's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -5.9% | +46.5% | -50.7% | — |
| ROA (TTM)Return on assets | -58.6% | +32.4% | -19.8% | -0.0% |
| ROICReturn on invested capital | -48.1% | +14.2% | +3.7% | -0.0% |
| ROCEReturn on capital employed | -30.5% | +12.4% | +4.3% | — |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 4 | 2 |
| Debt / EquityFinancial leverage | 0.37x | 0.23x | 1.35x | — |
| Net DebtTotal debt minus cash | -$22M | -$282M | $3.4B | $353M |
| Cash & Equiv.Liquid assets | $36M | $551M | $532M | $2M |
| Total DebtShort + long-term debt | $13M | $269M | $4.0B | $354M |
| Interest CoverageEBIT ÷ Interest expense | -7.21x | 63.45x | -7.20x | -780.16x |
Total Returns (Dividends Reinvested)
INVA leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in INVA five years ago would be worth $19,437 today (with dividends reinvested), compared to $271 for SNBR. Over the past 12 months, INVA leads with a +21.7% total return vs SNBR's -56.8%. The 3-year compound annual growth rate (CAGR) favors INVA at 25.0% vs SNBR's -49.6% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -69.9% | +14.7% | -13.5% | -64.7% |
| 1-Year ReturnPast 12 months | +17.4% | +21.7% | -51.2% | -56.8% |
| 3-Year ReturnCumulative with dividends | +4.2% | +95.2% | -58.1% | -87.2% |
| 5-Year ReturnCumulative with dividends | -96.5% | +94.4% | -60.1% | -97.3% |
| 10-Year ReturnCumulative with dividends | -96.4% | +94.9% | -77.7% | -87.6% |
| CAGR (3Y)Annualised 3-year return | +1.4% | +25.0% | -25.2% | -49.6% |
Risk & Volatility
INVA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
INVA is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than SNBR's 2.70 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. INVA currently trades 90.7% from its 52-week high vs SNBR's 21.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.05x | 0.13x | 1.18x | 2.70x |
| 52-Week HighHighest price in past year | $16.94 | $25.15 | $28.44 | $13.94 |
| 52-Week LowLowest price in past year | $3.99 | $16.52 | $9.23 | $1.07 |
| % of 52W HighCurrent price vs 52-week peak | +28.7% | +90.7% | +41.2% | +21.7% |
| RSI (14)Momentum oscillator 0–100 | 43.8 | 39.9 | 60.9 | 53.4 |
| Avg Volume (50D)Average daily shares traded | 341K | 621K | 3.4M | 2.8M |
Analyst Outlook
PRGO leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: OWLT as "Buy", INVA as "Buy", PRGO as "Hold", SNBR as "Hold". Consensus price targets imply 311.5% upside for OWLT (target: $20) vs 65.2% for INVA (target: $38). PRGO is the only dividend payer here at 9.81% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $20.00 | $37.67 | $20.00 | $10.00 |
| # AnalystsCovering analysts | 5 | 10 | 36 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | — | +9.8% | — |
| Dividend StreakConsecutive years of raises | — | 0 | 10 | — |
| Dividend / ShareAnnual DPS | — | — | $1.15 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% | 0.0% | +1.8% |
INVA leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 2 (Valuation Metrics, Analyst Outlook).
OWLT vs INVA vs PRGO vs SNBR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is OWLT or INVA or PRGO or SNBR a better buy right now?
For growth investors, Owlet, Inc.
(OWLT) is the stronger pick with 35. 4% revenue growth year-over-year, versus -99. 9% for Sleep Number Corporation (SNBR). Innoviva, Inc. (INVA) offers the better valuation at 6. 9x trailing P/E (11. 9x forward), making it the more compelling value choice. Analysts rate Owlet, Inc. (OWLT) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — OWLT or INVA or PRGO or SNBR?
On forward P/E, Perrigo Company plc is actually cheaper at 5.
6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — OWLT or INVA or PRGO or SNBR?
Over the past 5 years, Innoviva, Inc.
(INVA) delivered a total return of +94. 4%, compared to -97. 3% for Sleep Number Corporation (SNBR). Over 10 years, the gap is even starker: INVA returned +94. 9% versus OWLT's -96. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — OWLT or INVA or PRGO or SNBR?
By beta (market sensitivity over 5 years), Innoviva, Inc.
(INVA) is the lower-risk stock at 0. 13β versus Sleep Number Corporation's 2. 70β — meaning SNBR is approximately 2039% more volatile than INVA relative to the S&P 500. On balance sheet safety, Innoviva, Inc. (INVA) carries a lower debt/equity ratio of 23% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.
05Which is growing faster — OWLT or INVA or PRGO or SNBR?
By revenue growth (latest reported year), Owlet, Inc.
(OWLT) is pulling ahead at 35. 4% versus -99. 9% for Sleep Number Corporation (SNBR). On earnings-per-share growth, the picture is similar: Innoviva, Inc. grew EPS 816. 7% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, OWLT leads at 15. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — OWLT or INVA or PRGO or SNBR?
Innoviva, Inc.
(INVA) is the more profitable company, earning 63. 8% net margin versus -39. 6% for Owlet, Inc. — meaning it keeps 63. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INVA leads at 38. 5% versus -7. 9% for OWLT. At the gross margin level — before operating expenses — INVA leads at 72. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is OWLT or INVA or PRGO or SNBR more undervalued right now?
On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.
6x forward P/E versus 11. 9x for Innoviva, Inc. — 6. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OWLT: 311. 5% to $20. 00.
08Which pays a better dividend — OWLT or INVA or PRGO or SNBR?
In this comparison, PRGO (9.
8% yield) pays a dividend. OWLT, INVA, SNBR do not pay a meaningful dividend and should not be held primarily for income.
09Is OWLT or INVA or PRGO or SNBR better for a retirement portfolio?
For long-horizon retirement investors, Innoviva, Inc.
(INVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13)). Owlet, Inc. (OWLT) carries a higher beta of 2. 05 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (INVA: +94. 9%, OWLT: -96. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between OWLT and INVA and PRGO and SNBR?
These companies operate in different sectors (OWLT (Healthcare) and INVA (Healthcare) and PRGO (Healthcare) and SNBR (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: OWLT is a mid-cap high-growth stock; INVA is a small-cap high-growth stock; PRGO is a small-cap income-oriented stock; SNBR is a small-cap quality compounder stock. PRGO pays a dividend while OWLT, INVA, SNBR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.